ページの先頭です
HOME > Past Issue List > Issue List > Abstract
言語を選択(Language)
日本語(Japanese)English

Abstract

Vol.55 No.1 January 2007

Clinical efficacy of high dose treatment with teicoplanin (TEIC) against MRSA infections and trough concentration of TEIC

Yasuharu Ueda1), Shusaku Noguchi2), Masahiko Maki1), Hiroshi Kamisasa1), Toru Mochizuki1), Kyoko Unemoto1) and Akira Kurokawa1)

1)Department of Emergency and Critical Care Medicine, Nippon Medical School Musashikosugi Hospital,
1-396 Kosugi-cho, Nakahara-ku, Kawasaki, Kanagawa, Japan
2)Department of Pharmacy, Nippon Medical School Musashikosugi Hospital

Abstract

We analyzed the clinical efficacy of high dose teicoplanin (TEIC) (1,600 mg/24 h for the first day and 800 mg/24 h thereafter) and plasma trough concentration of TEIC in MRSA infections in Emergency and Critical Care Medicine, to examine the relationship between a change in the trough concentration after administration of this drug and efficacy and safety.
Results are as follows:
1. The clinical efficacy of TEIC against 10 cases of pneumonia, 2 of septicemia with wound infection due to MRSA was 100%.
2. The bacteriological effectiveness of TEIC consisted of 9 eradicated, 1 decreased, 2 replaced, and 0 unchanged. Among 8 patients treated with TEIC alone, it consisted of 7 eradicated, 0 decreased, 1 replaced, and 0 unchanged. Among 4 patients concomitantly treated with other drugs, it consisted of 2 eradicated, 1 decreased, 1 replaced, and 0 unchanged. Four of 12 patients showed multibacterial infection with Pseudomonas aeruginosa.
3. No case administered TEIC was found to have any side effects or abnormal laboratory findings.
4. The trough blood TEIC level slightly decreased to 17.5 ± 6.7 μg/mL on day 2 and 16.3 ± 6.3 μg/mL on day 4, showing a steady state, and accumulation of TEIC was as mild as 20.5 ± 6.9 μg/mL on day 8. There was no variation of blood concentrations in the respective patients, moreover.
5. High-dose treatment with TEIC showed highly sharp efficacy and high safety, which was considered to be a very useful method for treatment of severe MRSA infections.

Key word

MRSA, severe infection, teicoplanin, high dose administration, pharmacokinetics

Received

August 16, 2006

Accepted

November 22, 2006

Jpn. J. Chemother. 55 (1): 8-16, 2007